Utah Medical Products Inc. Common Stock (UTMD) fair value

ACCE thesis

Utah Medical Products makes low-volume, single-use and reusable medical devices, most notably disposable intrauterine pressure catheters for labor monitoring, along with infant feeding and fluid-management products. The durable edge is the 57.9% gross margin and 36.9% operating margin, which point to a niche franchise with pricing power and a small, loyal hospital customer base. The problem is top-line momentum: revenue is down 14.3%, so the margin story has to hold up while sales stabilize. A forward P/E of 13.0 against a trailing 22.8 says the market expects earnings to recover, and that gap is what a portfolio manager should test. ROE of 8.8% is modest for a business this profitable, which may reflect a large cash balance or buybacks, and that is worth checking before any conclusion. The company is too small for index membership, so the valuation case rests on fundamentals the fund would have to underwrite itself.